Results 31 to 40 of about 1,262,540 (239)

When Common Medications Trigger a Rare Reaction: A Review of Clinical Features, Diagnosis, and Treatment Options of DRESS Syndrome

open access: yesJournal of Education, Health and Sport, 2023
Introduction and purpose: Drug-induced reaction with eosinophilia and systemic symptoms (DRESS) is a severe, life-threatening systemic drug reaction.
Aleksandra Hajduk   +7 more
doaj   +1 more source

A Rare Presentation of Clozapine-Induced DRESS Syndrome

open access: yesCase Reports in Medicine, 2018
Drug reaction with eosinophilia and systemic symptoms (DRESS syndrome) is an uncommon side effect of certain medications. It causes a skin reaction, with eosinophilia and other organ involvement. This case describes a presentation of a 32-year-old female
Carmel Moazez   +3 more
doaj   +1 more source

SÍNDROME POR REACCIÓN A DROGAS CON EOSINOFILIA Y SÍNTOMAS SISTÉMICOS (DRESS)

open access: yesRevistas Argentina de Medicina, 2019
El síndrome DRESS (por sus siglas en inglés de drug rash with eosinophilia and systemic symptoms) es una reacción grave de hipersensibilidad a diferentes fármacos, entre los que podemos mencionar los anticonvulsivos, sulfonamidas y algunos fármacos ...
Hugo Milione   +3 more
doaj   +2 more sources

LAMOTRIGINE INDUCED DRESS SYNDROME [PDF]

open access: yes, 2017
Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome, is a type of hypersensitivity reaction, mainly due to anti-epileptic drugs. Lamotrigine is a newer broad spectrum antiepileptic that can be used in both children and adults.
O, Balaji   +4 more
core   +3 more sources

DRESS and Stevens–Johnson Syndrome Overlap Secondary to Allopurinol in a 50-Year-Old Man—A Diagnostic and Treatment Challenge: Case Report

open access: yesLife, 2023
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a drug reaction commonly related to eosinophilia, from uncertain epidemiology, and without consensus for diagnosis and treatment globally.
José Dario Martínez   +8 more
doaj   +1 more source

Targeting CD300a Signaling With a Phosphatidylserine‐Presenting Hydrogel Rescues Macrophage Dysfunction and Accelerates Diabetic Wound Healing

open access: yesAdvanced Healthcare Materials, EarlyView.
Schematic illustration of the proposed mechanism: PEG/RGD‐PSLs mimic apoptotic cells to engage PS receptors (notably CD300a), transducing an inhibitory signal that suppresses the MyD88/NF‐κB pathway, leading to global anti‐inflammatory and pro‐reparative effects.
Lele Wu   +10 more
wiley   +1 more source

Engineering Immunoregenerative Therapy via an Immunomodulatory Binary Pharmacology Hydrogel Depot for Prolonged Allograft Survival

open access: yesAdvanced Science, EarlyView.
An immunomodulatory hydrogel (iGEL) forms spontaneously upon subcutaneous injection, acting as a tissue‐adhesive depot. It releases anti‐rejection and regenerative agents in response to inflammation, suppressing T‐cell activity, promoting vascular repair, and restoring allograft function without systemic immunosuppression.
Ning Wang   +14 more
wiley   +1 more source

DRESS syndrome in a patient undergoing stem cell transplantation: Can sirolimus be involved?

open access: yesClinical Case Reports, 2023
We present a case of sirolimus‐induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome in a stem cell transplant patient. Sirolimus is an immunosuppressive drug that inhibits the mammalian target of rapamycin (mTOR) pathway.
Fortunato Cassalia   +4 more
doaj   +1 more source

Co-occurrence of clozapine-related DRESS syndrome core clinical manifestations: results of a systematic review

open access: yesEuropean Psychiatry, 2022
Introduction Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome refers to a cluster of clinical symptoms/signs related to drug hypersensitivity. The main clinical features include fever, skin rash, eosinophilia, enlarged lymph nodes,
R. De Filippis   +3 more
doaj   +1 more source

Engineering Approaches to Modify Immunomodulatory Functions of Mesenchymal Stromal Cells (MSCs): Tissue Regeneration and Clinical Application

open access: yesAdvanced Science, EarlyView.
Mesenchymal stromal cells (MSCs) show promise for treating immune‐related disorders through immunomodulation and tissue regeneration. This review gives a brief overview of current clinical approval of MSC therapies. It also discussed how bioengineering, including genetic modification, biomaterial delivery, extracellular vesicles, and iPSC‐derived MSCs,
Sichen Yang   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy